Light chain deposition disease involving kidney and liver in a patient with IgD myelomaCASE REPORT Open Access Light chain deposition disease involving kidney and liver in

Microsoft PowerPoint - Brunner_Janet_PaperID_1672.pptxSharing knowledge. Sharing hope. Forms Revision: Myeloma Changes J. Brunner, PA-C and A. Dispenzieri, MD February 2013

ISSN: 2059-268X Two cases of multiple myeloma, presenting with light- chain tubulopathy Elena V Zakharova1,2*, Alina M Anilina1, Elena V Zvonova1, Tatyana R Jylinskaya2 and

The Complexity and Heterogeneity of Monoclonal Immunoglobulin–Associated Renal DiseasesSanjeev Sethi,1 S. Vincent Rajkumar,2 and Vivette D. D’Agati3 1Department

PII: S0889-8588(05)70123-4~~ Joel Buxbaum, MD, and Gloria Gallo, MD B-cell proliferative disorders may display their pathogenic effects by in- creased cell numbers, increased

SERUM FREE LIGHT CHAIN TESTING AND WALDENSTRÖM MACROGLOBULINEMIA by Neal Makens, MD Introduction Antibodies (immunoglobulins) are proteins produced by plasma cells (and

jasn2016008 1..5Nelson Leung, MD INTRODUCTION Monoclonal gammopathy is a hallmark of plasma cell dyscrasias and some B-cell lymphoprolife- rative disorders (1). They cover

The role of the laboratory Learning Objectives • Compare traditional myeloma testing methods with current recommended protocols and describe how kappa & lambda free

Pulmonary Vascular Disease Due to Plasma Cell DyscrasiaCASE REPORT From the Division of Cardio- vascular Disease, Section of Advanced Heart Failure and Transplantation (I.R.,

Light chain deposition disease: atypical associations in a rare disease Ivo Cunha1, Sandra Silva2, Rui Henrique3, Maximino Costa2 1 Serviço de Medicina Interna do